Trial of Afatinib in Pediatric Tumours
NCT02372006
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuroectodermal Tumors
Rhabdomyosarcoma
Interventions
DRUG:
afatinib
Sponsor
Boehringer Ingelheim